Jenny Dick

Years Active: 2023-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Renata Varaljai, Lisa Zimmer, Yahya Al-Matary, Paulien Kaptein, Lea J Albrecht, Batool Shannan, Jan C Brase, Daniel Gusenleitner, Teresa Amaral, Nina Wyss, Jochen Utikal, Lukas Flatz, Florian Rambow, Hans Christian Reinhardt, Jenny Dick, Daniel R Engel, Susanne Horn, Selma Ugurel, Wiebke Sondermann, Elisabeth Livingstone, Antje Sucker, Annette Paschen, Fang Zhao, Jan M Placke, Jasmin M Klose, Wolfgang P Fendler, Daniela S Thommen, Iris Helfrich, Dirk Schadendorf, Alexander Roesch
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Nature cancer (2023)
Renata Varaljai, Lisa Zimmer, Yahya Al-Matary, Paulien Kaptein, Lea J Albrecht, Batool Shannan, Jan C Brase, Daniel Gusenleitner, Teresa Amaral, Nina Wyss, Jochen Utikal, Lukas Flatz, Florian Rambow, Hans Christian Reinhardt, Jenny Dick, Daniel R Engel, Susanne Horn, Selma Ugurel, Wiebke Sondermann, Elisabeth Livingstone, Antje Sucker, Annette Paschen, Fang Zhao, Jan M Placke, Jasmin M Klose, Wolfgang P Fendler, Daniela S Thommen, Iris Helfrich, Dirk Schadendorf, Alexander Roesch
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Nature cancer (2023)

Jenny Dick.css-eqlu8i{font-size:small;padding-left:4px;}